Related Experiment Video
Updated: Sep 27, 2026

Isolation, Behavioral Identification, and Pathogenicity Assessment of Entomopathogenic Fungi from a Forest Wood Borer
Published on: September 29, 2023
Emerging and less common fungal pathogens
Rhonda V Fleming1, Thomas J Walsh, Elias J Anaissie
1Division of Infectious Diseases, Boston University Medical Center, Boston, MA, USA.
Abstract:
Less common and emerging fungal pathogens are often resistant to conventional antifungal therapy and may cause severe morbidity and mortality in immunocompromised hosts. Some Scedosporium species may be completely resistant to antifungal therapy. Hyaline septated filamentous fungi, such as Fusarium species, Acremonium species, Paecilomyces species, and Trichoderma species, are increasingly reported as causing invasive mycoses refractory to amphotericin B therapy. Dematiaceous septated filamentous fungi, such as Bipolaris species may cause pneumonia, sinusitis, and CNS infections that are unresponsive to current medical interventions. Trichosporon spp are resistant to the fungicidal effects of amphotericin B. An increasing number of different members of the class Zygomycetes are reported as causing lethal infections, despite aggressive medical and surgical interventions. Infections due to these and other less common and emergent fungal pathogens will likely continue to develop in the settings of selective anti-fungal pressure, permissive environmental conditions, and an expanding population of immunocompromised hosts.
Insights
Emerging fungal pathogens, including Scedosporium and Fusarium species, often resist standard antifungal treatments. These infections pose significant risks, especially for immunocompromised individuals, necessitating new therapeutic strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Immunocompromised Host Research
Background:
- Less common and emerging fungal pathogens present significant challenges in clinical settings.
- Many of these fungi exhibit resistance to conventional antifungal therapies, leading to severe outcomes.
Purpose of the Study:
- To highlight the growing threat of invasive mycoses caused by resistant fungal pathogens.
- To underscore the limitations of current antifungal treatments against specific fungal species.
Main Methods:
- Review of clinical case reports and epidemiological data on emerging fungal infections.
- Analysis of antifungal resistance patterns in various fungal genera like Fusarium, Scedosporium, and Zygomycetes.
Main Results:
- Invasive mycoses caused by Fusarium, Acremonium, Paecilomyces, Trichoderma, Bipolaris, and Trichosporon species are increasingly refractory to standard therapies, including amphotericin B.
- Zygomycetes infections are frequently lethal despite aggressive treatment.
- Scedosporium species can be completely resistant to antifungal agents.
Conclusions:
- The rise of antifungal resistance in less common fungal pathogens is a critical concern for immunocompromised populations.
- Continued emergence of these infections is expected due to antifungal pressure, environmental factors, and a growing immunocompromised host population.
- Development of novel antifungal strategies is imperative to combat these refractory infections.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cryptococcal Meningitis

